Immunohistochemical Evaluation of Oxidative Stress Markers in Chronic Hepatitis C

Sabina Mahmood, Miwa Kawanaka, Ayumi Kamei, Akiyoshi Izumi, Keiichi Nakata, Gouichi Niiyama, Hideji Ikeda, Shinichi Hanano, Mitsuhiko Suehiro, Kazumi Togawa, Gotaro Yamada

Research output: Contribution to journalArticle

85 Citations (Scopus)

Abstract

Oxidative stress (OS) plays a major role in chronic hepatitis C. Various OS markers have been found to be elevated in hepatitis C virus (HCV)-related liver disease. This study detected the presence of OS in serum and liver biopsy specimens of HCV patients. Reactive oxygen molecules (ROM) in sera of 54 HCV patients were compared with 23 controls. OS markers 8-hydroxydeoxyguanosine (8-OHdG), 4-hydroxy-2-nonenal, malondialdehyde, and thioredoxin were measured in liver biopsy specimens of 18 HCV patients with fibrosis staging F1 (six); F2 (two), F3 (four), and F4 (six). The interferon (IFN) response and hepatocellular carcinoma (HCC) occurrence in the presence of OS markers were also evaluated. The level of ROM in HCV patients was 318 ± 56.7 Carr compared with 248 ± 40.8 Carr in controls (p = 0.032). Multivariate analysis found age (p = 0.0236) to be the only independent variable associated with increase in ROM in sera. In liver biopsy specimens, OS markers were found mainly around the area of piecemeal necrosis or the periportal area. The presence of OS markers seemed to increase with fibrosis staging, although not significantly. The OS DNA damage marker 8-OHdG was detected in the nucleus of hepatocytes. Thirteen patients received IFN therapy. During the 4-year follow-up period, HCC developed in four nonresponders to IFN and in one untreated patient. OS markers were stained in both HCC cells and non-HCC cells in HCC patients. OS markers were found in serum and liver specimens of HCV-associated liver disease and in HCC tissue. Detection of OS markers may be important for monitoring disease progression in HCV patients. Antioxidant therapy in combination with antiviral therapy may minimize liver damage and aid in the prevention and subsequent development of HCC.

Original languageEnglish
Pages (from-to)19-24
Number of pages6
JournalAntioxidants and Redox Signaling
Volume6
Issue number1
Publication statusPublished - Feb 2004
Externally publishedYes

Fingerprint

Oxidative stress
Chronic Hepatitis C
Oxidative Stress
Viruses
Hepacivirus
Liver
Hepatocellular Carcinoma
Biopsy
Interferons
Oxygen
Serum
Molecules
Liver Diseases
Fibrosis
Thioredoxins
Malondialdehyde
Genetic Markers
DNA Damage
Antiviral Agents
Disease Progression

ASJC Scopus subject areas

  • Biochemistry

Cite this

Mahmood, S., Kawanaka, M., Kamei, A., Izumi, A., Nakata, K., Niiyama, G., ... Yamada, G. (2004). Immunohistochemical Evaluation of Oxidative Stress Markers in Chronic Hepatitis C. Antioxidants and Redox Signaling, 6(1), 19-24.

Immunohistochemical Evaluation of Oxidative Stress Markers in Chronic Hepatitis C. / Mahmood, Sabina; Kawanaka, Miwa; Kamei, Ayumi; Izumi, Akiyoshi; Nakata, Keiichi; Niiyama, Gouichi; Ikeda, Hideji; Hanano, Shinichi; Suehiro, Mitsuhiko; Togawa, Kazumi; Yamada, Gotaro.

In: Antioxidants and Redox Signaling, Vol. 6, No. 1, 02.2004, p. 19-24.

Research output: Contribution to journalArticle

Mahmood, S, Kawanaka, M, Kamei, A, Izumi, A, Nakata, K, Niiyama, G, Ikeda, H, Hanano, S, Suehiro, M, Togawa, K & Yamada, G 2004, 'Immunohistochemical Evaluation of Oxidative Stress Markers in Chronic Hepatitis C', Antioxidants and Redox Signaling, vol. 6, no. 1, pp. 19-24.
Mahmood S, Kawanaka M, Kamei A, Izumi A, Nakata K, Niiyama G et al. Immunohistochemical Evaluation of Oxidative Stress Markers in Chronic Hepatitis C. Antioxidants and Redox Signaling. 2004 Feb;6(1):19-24.
Mahmood, Sabina ; Kawanaka, Miwa ; Kamei, Ayumi ; Izumi, Akiyoshi ; Nakata, Keiichi ; Niiyama, Gouichi ; Ikeda, Hideji ; Hanano, Shinichi ; Suehiro, Mitsuhiko ; Togawa, Kazumi ; Yamada, Gotaro. / Immunohistochemical Evaluation of Oxidative Stress Markers in Chronic Hepatitis C. In: Antioxidants and Redox Signaling. 2004 ; Vol. 6, No. 1. pp. 19-24.
@article{7853335036804b9c959f612307d4988c,
title = "Immunohistochemical Evaluation of Oxidative Stress Markers in Chronic Hepatitis C",
abstract = "Oxidative stress (OS) plays a major role in chronic hepatitis C. Various OS markers have been found to be elevated in hepatitis C virus (HCV)-related liver disease. This study detected the presence of OS in serum and liver biopsy specimens of HCV patients. Reactive oxygen molecules (ROM) in sera of 54 HCV patients were compared with 23 controls. OS markers 8-hydroxydeoxyguanosine (8-OHdG), 4-hydroxy-2-nonenal, malondialdehyde, and thioredoxin were measured in liver biopsy specimens of 18 HCV patients with fibrosis staging F1 (six); F2 (two), F3 (four), and F4 (six). The interferon (IFN) response and hepatocellular carcinoma (HCC) occurrence in the presence of OS markers were also evaluated. The level of ROM in HCV patients was 318 ± 56.7 Carr compared with 248 ± 40.8 Carr in controls (p = 0.032). Multivariate analysis found age (p = 0.0236) to be the only independent variable associated with increase in ROM in sera. In liver biopsy specimens, OS markers were found mainly around the area of piecemeal necrosis or the periportal area. The presence of OS markers seemed to increase with fibrosis staging, although not significantly. The OS DNA damage marker 8-OHdG was detected in the nucleus of hepatocytes. Thirteen patients received IFN therapy. During the 4-year follow-up period, HCC developed in four nonresponders to IFN and in one untreated patient. OS markers were stained in both HCC cells and non-HCC cells in HCC patients. OS markers were found in serum and liver specimens of HCV-associated liver disease and in HCC tissue. Detection of OS markers may be important for monitoring disease progression in HCV patients. Antioxidant therapy in combination with antiviral therapy may minimize liver damage and aid in the prevention and subsequent development of HCC.",
author = "Sabina Mahmood and Miwa Kawanaka and Ayumi Kamei and Akiyoshi Izumi and Keiichi Nakata and Gouichi Niiyama and Hideji Ikeda and Shinichi Hanano and Mitsuhiko Suehiro and Kazumi Togawa and Gotaro Yamada",
year = "2004",
month = "2",
language = "English",
volume = "6",
pages = "19--24",
journal = "Antioxidants and Redox Signaling",
issn = "1523-0864",
publisher = "Mary Ann Liebert Inc.",
number = "1",

}

TY - JOUR

T1 - Immunohistochemical Evaluation of Oxidative Stress Markers in Chronic Hepatitis C

AU - Mahmood, Sabina

AU - Kawanaka, Miwa

AU - Kamei, Ayumi

AU - Izumi, Akiyoshi

AU - Nakata, Keiichi

AU - Niiyama, Gouichi

AU - Ikeda, Hideji

AU - Hanano, Shinichi

AU - Suehiro, Mitsuhiko

AU - Togawa, Kazumi

AU - Yamada, Gotaro

PY - 2004/2

Y1 - 2004/2

N2 - Oxidative stress (OS) plays a major role in chronic hepatitis C. Various OS markers have been found to be elevated in hepatitis C virus (HCV)-related liver disease. This study detected the presence of OS in serum and liver biopsy specimens of HCV patients. Reactive oxygen molecules (ROM) in sera of 54 HCV patients were compared with 23 controls. OS markers 8-hydroxydeoxyguanosine (8-OHdG), 4-hydroxy-2-nonenal, malondialdehyde, and thioredoxin were measured in liver biopsy specimens of 18 HCV patients with fibrosis staging F1 (six); F2 (two), F3 (four), and F4 (six). The interferon (IFN) response and hepatocellular carcinoma (HCC) occurrence in the presence of OS markers were also evaluated. The level of ROM in HCV patients was 318 ± 56.7 Carr compared with 248 ± 40.8 Carr in controls (p = 0.032). Multivariate analysis found age (p = 0.0236) to be the only independent variable associated with increase in ROM in sera. In liver biopsy specimens, OS markers were found mainly around the area of piecemeal necrosis or the periportal area. The presence of OS markers seemed to increase with fibrosis staging, although not significantly. The OS DNA damage marker 8-OHdG was detected in the nucleus of hepatocytes. Thirteen patients received IFN therapy. During the 4-year follow-up period, HCC developed in four nonresponders to IFN and in one untreated patient. OS markers were stained in both HCC cells and non-HCC cells in HCC patients. OS markers were found in serum and liver specimens of HCV-associated liver disease and in HCC tissue. Detection of OS markers may be important for monitoring disease progression in HCV patients. Antioxidant therapy in combination with antiviral therapy may minimize liver damage and aid in the prevention and subsequent development of HCC.

AB - Oxidative stress (OS) plays a major role in chronic hepatitis C. Various OS markers have been found to be elevated in hepatitis C virus (HCV)-related liver disease. This study detected the presence of OS in serum and liver biopsy specimens of HCV patients. Reactive oxygen molecules (ROM) in sera of 54 HCV patients were compared with 23 controls. OS markers 8-hydroxydeoxyguanosine (8-OHdG), 4-hydroxy-2-nonenal, malondialdehyde, and thioredoxin were measured in liver biopsy specimens of 18 HCV patients with fibrosis staging F1 (six); F2 (two), F3 (four), and F4 (six). The interferon (IFN) response and hepatocellular carcinoma (HCC) occurrence in the presence of OS markers were also evaluated. The level of ROM in HCV patients was 318 ± 56.7 Carr compared with 248 ± 40.8 Carr in controls (p = 0.032). Multivariate analysis found age (p = 0.0236) to be the only independent variable associated with increase in ROM in sera. In liver biopsy specimens, OS markers were found mainly around the area of piecemeal necrosis or the periportal area. The presence of OS markers seemed to increase with fibrosis staging, although not significantly. The OS DNA damage marker 8-OHdG was detected in the nucleus of hepatocytes. Thirteen patients received IFN therapy. During the 4-year follow-up period, HCC developed in four nonresponders to IFN and in one untreated patient. OS markers were stained in both HCC cells and non-HCC cells in HCC patients. OS markers were found in serum and liver specimens of HCV-associated liver disease and in HCC tissue. Detection of OS markers may be important for monitoring disease progression in HCV patients. Antioxidant therapy in combination with antiviral therapy may minimize liver damage and aid in the prevention and subsequent development of HCC.

UR - http://www.scopus.com/inward/record.url?scp=0346340016&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0346340016&partnerID=8YFLogxK

M3 - Article

C2 - 14713333

AN - SCOPUS:0346340016

VL - 6

SP - 19

EP - 24

JO - Antioxidants and Redox Signaling

JF - Antioxidants and Redox Signaling

SN - 1523-0864

IS - 1

ER -